SARS-CoV-2 can directly infect and inflame the vagus nerve, and this damage appears to be a key driver of the nerve pain, fatigue, racing heartbeat, gut dysfunction, and chronic cough that plague many people with long COVID. Autopsy studies have found viral RNA in vagus nerve tissue from every COVID-19 patient examined, along with thousands of upregulated inflammatory genes, painting a picture of a nerve under sustained biological assault. Roughly one in five people who develop new pain after COVID report it has neuropathic characteristics, and understanding why the vagus nerve is so vulnerable helps explain symptoms that might otherwise seem unrelated to each other.
How Common Is Nerve Pain After COVID
Estimates vary depending on which patients are studied and how “neuropathic pain” is defined, but the numbers are consistently high enough to qualify this as a major long COVID problem. A meta-analysis pooling six studies of long COVID patients found that about a third had neuropathic pain, though the confidence interval was wide because the individual studies used different assessment methods and timeframes.1PubMed Central. COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis – Section: Results A separate study that distinguished pain types among long COVID patients found that about 20% of those with new-onset pain had neuropathic pain specifically, and these individuals reported lower quality of life and higher rates of cognitive problems compared to those whose pain was non-neuropathic.2Frontiers in Rehabilitation Sciences. Distinguishing pain profiles among individuals with long COVID – Section: Results
Zooming out further, a narrative review estimated that roughly 10% of all SARS-CoV-2 infections lead to post-acute neuropathic complications, which, given the scale of the pandemic, translates to around 65 million people worldwide.3PubMed Central. Post-acute sequelae SARS-CoV-2 infection and neuropathic pain: a narrative review of the literature and future directions – Section: Abstract The pain can take many forms. A systematic review of individual case reports documented patients presenting with burning pain, trigeminal neuralgia, small fiber polyneuropathy, and brachial plexopathy, with symptom onset ranging from a few days before COVID diagnosis to more than six weeks afterward.4PubMed Central. Neuropathic Pain Associated with COVID-19: a Systematic Review of Case Reports – Section: Evidence Synthesis That wide timeline makes it tricky for patients and clinicians alike to connect nerve pain to a prior infection, especially when the acute illness was mild.
Why the Vagus Nerve Is Central to the Story
The vagus nerve is the longest cranial nerve in the body, running from the brainstem down through the neck and into the chest and abdomen. It carries signals in both directions: sensory information flows up from organs to the brain, and regulatory commands flow back down. It controls heart rate, digestion, breathing rhythm, swallowing, voice production, and the cough reflex. Perhaps most relevant to COVID, the vagus nerve also acts as a built-in brake on inflammation. Through what researchers call the inflammatory reflex, the nerve detects signs of immune activation in the body and sends signals back to dial it down.5Nature. The inflammatory reflex
The way this brake works is that signals traveling along the vagus nerve and into the spleen trigger the release of acetylcholine, which acts on immune cells to reduce their production of inflammatory molecules.6Cell Reports Medicine. Manipulation of the inflammatory reflex as a therapeutic strategy – Section: Summary The vagus nerve essentially lets the brain regulate immune responses in real time, the same way it adjusts heart rate or breathing.7PubMed Central. The vagus nerve and the inflammatory reflex–linking immunity and metabolism – Section: Abstract Damage the vagus nerve, and you lose that brake. Inflammation can run unchecked, which in turn can damage more tissue, including more nerve tissue, creating a feedback loop that helps explain why long COVID symptoms persist for months or years.
How SARS-CoV-2 Gets Into the Vagus Nerve
For a long time, researchers suspected the vagus nerve was involved in COVID dysautonomia but lacked direct proof. That changed with a study that collected vagus nerve tissue from 27 people who had died of COVID-19 and five controls who died of other causes. RNA sequencing revealed over 2,000 genes that were significantly upregulated in the COVID patients’ vagus nerves, heavily concentrated in antiviral and interferon-signaling pathways. More strikingly, SARS-CoV-2 RNA was detectable in every single COVID patient’s vagus nerve sample and in none of the controls.8PubMed Central. Vagus nerve inflammation contributes to dysautonomia in COVID-19 – Section: Results and discussion
This confirmed that the virus does not merely trigger distant inflammation that happens to affect the nerve. It physically invades the tissue. Researchers have proposed multiple routes: the virus may travel along nerve fibers from the lungs or gut (both densely innervated by the vagus), or it may enter via the bloodstream and cross into the nerve where the blood-nerve barrier is weak. Additional autopsy evidence has found viral proteins in cranial nerves originating from the lower brainstem, suggesting that the infection can climb all the way to the brain’s nerve-control centers.9PubMed. Vagus nerve SARS-CoV-2 infection and inflammatory reflex dysfunction: Is there a causal relationship? In a study of brain tissue from 40 COVID-19 fatalities, SARS-CoV-2 was found in over half, with brainstem involvement and widespread neuroimmune activation.10Scientific Archives. Neurological Manifestations Associated with SARS-CoV-2 Invasion of the Autonomous Nervous System
The brainstem houses the dorsal vagal complex, the control hub for the vagus nerve’s functions. When inflammation or viral invasion reaches this area, it can disrupt signals to and from the heart, lungs, and gut simultaneously, which helps explain the bewildering variety of symptoms long COVID patients experience.
Autoantibodies That Keep the Damage Going
Viral invasion alone does not explain why symptoms persist long after the acute infection clears. A growing body of evidence points to autoantibodies as a second, sustained mechanism of nerve injury. During acute COVID, the immune system produces antibodies against the virus, but some of these cross-react with the body’s own proteins, including those found on nerve cells and blood vessels. In long COVID patients, the prevalence and concentration of autoantibodies targeting autonomic and blood-vessel-regulating receptors were significantly higher than in both recovered individuals without long COVID and healthy controls, with more patients carrying multiple autoantibody types at once.11PubMed. Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors – Section: RESULTS
Recent experimental work has gone further, demonstrating a causal link rather than just a correlation. Researchers found that people with long COVID and neurocognitive symptoms had increased autoantibodies against both central and peripheral nervous system proteins. When purified antibodies from these patients were injected into mice, the animals developed fatigue-like behavior, loss of coordination, heightened pain sensitivity, and small fiber nerve damage, essentially reproducing the patients’ symptoms in an animal model.12Cell. A causal link between autoantibodies and neurological symptoms in Long COVID – Section: Abstract This is a significant finding because it moves the conversation beyond “something is wrong” to “here is what is causing it,” and it opens the door to treatments that specifically target autoantibodies.
Microvascular Damage Adds Another Layer
Nerves need blood supply to function, and SARS-CoV-2 is ruthless toward small blood vessels. The virus causes swelling and damage to the endothelial cells lining capillaries, triggers microscopic blood clots, and injures pericytes, the cells that maintain capillary integrity and help with tissue repair.13PubMed Central. SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation – Section: Abstract When the tiny vessels feeding a nerve are clogged or leaky, the nerve fibers they supply become starved of oxygen. This ischemic injury can produce the burning, tingling, and shooting pain typical of neuropathy. It also contributes to the general fatigue and brain fog of long COVID, since the brain is even more sensitive to oxygen deprivation than peripheral nerves.
The combination of direct viral invasion, autoimmune attack, and microvascular strangulation means the vagus nerve and other peripheral nerves face a three-front assault. Each mechanism can persist independently of the others, which is one reason long COVID nerve pain does not follow a single predictable timeline.
Symptoms You Might Not Connect to Nerve Damage
Because the vagus nerve touches so many organ systems, its dysfunction produces a symptom profile that looks chaotic from the outside. Patients often bounce between specialists, each addressing one piece of the puzzle. Some of the most common vagus-related complaints go well beyond what most people think of as “nerve pain.”
Chronic cough is a hallmark. Laryngeal electromyography studies on people with persistent post-COVID cough have found patterns consistent with vagus nerve neuropathy, meaning the nerve controlling the larynx and cough reflex is not working properly.14PubMed Central. Chronic cough in post-COVID syndrome: Laryngeal electromyography findings in vagus nerve neuropathy – Section: Conclusions The cough reflex becomes hypersensitive, essentially stuck in an overactive state. This appears to happen because SARS-CoV-2’s affinity for nerve tissue leads to inflammation along the vagal sensory fibers that regulate coughing.15PubMed Central. Approach to post COVID-19 persistent cough: A narrative review – Section: Abstract The result is a dry, hacking cough that persists for months without any sign of ongoing lung infection.
Gastrointestinal problems are another common thread. Nausea, vomiting, and abnormal gut motility in COVID patients have been linked to vagal nerve stimulation of the dorsal medulla by inflammatory mediators released from cells in the gut lining. The virus can also reach the brainstem’s dorsal vagal complex through retrograde neuronal transport, and severe COVID-related oxygen deprivation can directly damage this area.16PubMed Central. COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review People who develop unexplained nausea, early satiety, or gastroparesis-like symptoms after COVID may be dealing with vagal dysfunction rather than a primary stomach disorder.
Heart rate instability rounds out the picture. Long COVID patients frequently show lower heart rate variability, impaired vagal tone, and a shift toward sympathetic (fight-or-flight) dominance.17PubMed Central. Cardiovascular autonomic dysfunction in “Long COVID”: pathophysiology, heart rate variability, and inflammatory markers – Section: Abstract In practice, this means a heart that races on standing, does not slow down properly at rest, and responds erratically to exercise. Many of these patients meet criteria for postural orthostatic tachycardia syndrome (POTS), and the vagus nerve’s impaired ability to restrain heart rate is a likely explanation.
Visible Evidence on Ultrasound
One of the more compelling recent developments is that vagus nerve damage in COVID patients can actually be seen with ultrasound. Researchers measuring the cross-sectional area of the vagus nerve in COVID-19 patients found it was substantially enlarged compared to controls, with the most dramatic differences on the right side, where the nerve area was roughly double that of healthy individuals.18International Journal of Medical Students. Vagus Nerve Neuropathy in SARS-CoV-2 Infection: An Ultrasound Study – Section: Results This swelling was observed despite the patient group being older on average, a factor that would normally predict smaller nerve dimensions. The finding reinforces that the enlargement reflects pathological inflammation rather than normal variation.
A separate study looked at whether standard blood markers of inflammation correlated with this nerve swelling. It found that inflammatory biomarkers were significantly associated with abnormal right vagus nerve size on ultrasound, with the statistical model showing reasonable ability to distinguish affected patients.19PubMed Central. Association between vagus nerve cross-sectional area measured by ultrasound and inflammatory biomarkers in hospitalised patients with COVID-19 – Section: RESULTS The asymmetry between left and right sides is itself interesting and remains poorly understood, but it suggests that the right vagus nerve, which has a slightly different anatomical course and innervation pattern, may be more exposed to viral entry or inflammatory damage.
These imaging findings matter for patients because they offer an objective marker. Many people with long COVID nerve pain struggle to be taken seriously when standard blood tests come back normal. An ultrasound showing a visibly swollen vagus nerve provides concrete evidence that something measurable has changed.
Vagus Nerve Stimulation as a Potential Treatment
If the vagus nerve’s anti-inflammatory brake is broken, a logical question is whether you can jump-start it externally. Vagus nerve stimulation (VNS) uses mild electrical pulses delivered either through an implanted device or, more commonly in the long COVID context, through a handheld device placed on the skin of the neck or ear. The idea is to activate the same anti-inflammatory pathway the nerve normally runs on its own, potentially reducing systemic inflammation, improving blood flow to the brain, and rebalancing the autonomic nervous system.20PubMed Central. Transcutaneous vagus nerve stimulation improves Long COVID symptoms in a female cohort: a pilot study – Section: Discussion
The early results are genuinely encouraging but far from conclusive. A pilot study in women with long COVID found improvements in symptoms with transcutaneous VNS, and the treatment’s theoretical basis is sound given what we know about the inflammatory reflex. However, a randomized controlled trial comparing transcutaneous VNS to a control group found that while participants receiving stimulation showed improvements in depression scores, fatigue, and autonomic dysfunction measures, none of these differences reached statistical significance.21PubMed Central. The Use of a Handheld Non-Invasive Vagal Nerve Stimulation (nVNS) Device for the Treatment of Long COVID: A Pilot Randomized Controlled Trial – Section: Results Stress hormones also rose less in the VNS group, but again, the difference was not statistically significant. The overall picture is a treatment that trends in the right direction but has not yet been proven in adequately sized trials.22Infectious Medicine. Vagal nerve stimulation for the management of long COVID symptoms – Section: Abstract
For patients considering VNS, the good news is that the non-invasive version has a favorable safety profile. It does not require surgery, and side effects tend to be mild. The bad news is that the devices can be expensive, insurance coverage is inconsistent, and the evidence base is still built on small pilot studies rather than large definitive trials. Anyone exploring this option should understand that “promising” and “proven” are different things.
Who Faces Higher Risk
Not everyone who gets COVID develops nerve pain or vagal dysfunction. Research into risk factors for neurological long COVID symptoms has identified several patterns: older age, female sex, having certain pre-existing conditions, and experiencing a larger number of symptoms during the acute illness all increase the likelihood of persistent neurological problems. The dysautonomia that results from vagal damage is frequently reported in long COVID and can persist for years, with some researchers anticipating it may be lifelong in a subset of patients.8PubMed Central. Vagus nerve inflammation contributes to dysautonomia in COVID-19 – Section: Results and discussion
The female predominance in vagal-related long COVID symptoms is worth noting. Women are overrepresented in long COVID cohorts generally, and multiple VNS studies have either focused exclusively on women or found that their samples skewed heavily female. Whether this reflects differences in immune response, hormonal factors, autonomic nervous system baseline characteristics, or simply that women seek medical care more readily remains an open question. It does mean, however, that a woman with post-COVID nerve pain, unexplained tachycardia, and gut problems is not dealing with something unusual. She is dealing with something common that medicine is still learning to recognize and treat.
The Brainstem Angle
Most discussion of vagus nerve damage in COVID focuses on the peripheral nerve running through the neck and torso. But the brainstem end of the story may matter just as much. The dorsal vagal complex in the medulla oblongata serves as mission control for the vagus nerve, and it is vulnerable to both direct viral invasion and hypoxic injury from severe COVID. When inflammatory mediators from the gut stimulate vagal afferents, the signals project to the dorsal medulla and from there to higher brain regions, producing nausea, vomiting, and autonomic instability.16PubMed Central. COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review Damage at this central relay station could amplify problems with every organ the vagus nerve serves, even if the peripheral nerve itself recovers.
The brainstem’s involvement also raises the possibility of central sensitization, a phenomenon in which the nervous system’s pain-processing circuitry becomes persistently overactive. Once brainstem neurons are inflamed or injured, they can amplify normal sensory signals into pain signals, making the body feel like it is under attack even when no new tissue damage is occurring. This may explain why some long COVID patients develop widespread pain sensitivity that extends far beyond the distribution of any single nerve. It also suggests that treatment strategies focused only on the peripheral vagus nerve may miss part of the problem, and that addressing central nervous system inflammation will be an important piece of the long-term therapeutic puzzle.
Small Fiber Neuropathy and Its Connection to the Vagus
Many long COVID patients who undergo specialized testing receive a diagnosis of small fiber neuropathy, meaning the smallest nerve fibers in the skin and organs are damaged. These fibers carry pain and temperature signals and regulate blood vessel tone and sweating. The connection to the vagus nerve is direct: the vagus contains both large myelinated fibers and small unmyelinated C fibers, and the autoantibody research described earlier showed that transferring long COVID patients’ antibodies into mice produced measurable small fiber nerve damage alongside pain-related neuronal overactivity.12Cell. A causal link between autoantibodies and neurological symptoms in Long COVID – Section: Abstract This means the same autoimmune process attacking the vagus can simultaneously damage small fibers throughout the body, producing the burning feet, heat intolerance, and patchy sweating abnormalities that many patients report.
Skin punch biopsy, the standard diagnostic test for small fiber neuropathy, measures the density of these tiny nerve endings in a sample of skin. For people with post-COVID nerve pain who have been told their standard nerve conduction studies are normal, requesting a skin biopsy from a neurologist familiar with small fiber testing can be the difference between a diagnosis and continued dismissal. Standard nerve conduction studies only measure large fibers and will miss the small fiber damage that autoantibodies and microvascular injury tend to cause.